| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.0003 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0003 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.13 | 0.002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |